GlaxoSmithKline has filed its new COPD triple therapy with the FDA a full 18 months early, giving it a much needed boost in its respiratory franchise. The once-daily, 'closed triple therapy ...

A year after narrowing its recommendation for who should use vaccines to defend against respiratory syncytial virus (RSV), a ...

A single-dose of the respiratory syncytial virus (RSV) vaccine in older adults showed waning efficacy across three seasons of ...

Wall Street watches a company's quarterly report closely to understand as much as possible about its recent performance and what to expect going forward. Of course, one figure often stands out among ...

Save the Children and GSK have partnered together in the U.S since 2015, providing immediate emergency relief to children and families when disaster strikes and working to build safer and more ...

GSK already scores pretty well among the top 14 pharma companies when it comes to R&D efficiency – ranking third behind Pfizer and Novartis in an analysis of R&D productivity published last year ...

GSK has secured the first regulatory approval for Blenrep since the antibody-drug conjugate’s global market withdrawal in 2022. | GSK has secured the first regulatory approval for Blenrep since the ...